[
  {
    "ts": "2025-02-13T15:35:27+00:00",
    "headline": "Conduit Pharmaceuticals, Charles River Laboratories Partner to Evaluate Potential Lupus Treatment",
    "summary": "Conduit Pharmaceuticals (CDT) said Thursday it partnered with Charles River Laboratories Internation",
    "url": "https://finance.yahoo.com/news/conduit-pharmaceuticals-charles-river-laboratories-153527269.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "a300e60f-c88f-3e16-ac18-127a4b72a2d4",
      "content": {
        "id": "a300e60f-c88f-3e16-ac18-127a4b72a2d4",
        "contentType": "STORY",
        "title": "Conduit Pharmaceuticals, Charles River Laboratories Partner to Evaluate Potential Lupus Treatment",
        "description": "",
        "summary": "Conduit Pharmaceuticals (CDT) said Thursday it partnered with Charles River Laboratories Internation",
        "pubDate": "2025-02-13T15:35:27Z",
        "displayTime": "2025-02-13T15:35:27Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/conduit-pharmaceuticals-charles-river-laboratories-153527269.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/conduit-pharmaceuticals-charles-river-laboratories-153527269.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]